Santen
Japanese pharmaceutical company specializing in the development and manufacturing of ophthalmic products.
Launch date
Employees
Market cap
-
Enterprise valuation
€55—82m (Dealroom.co estimates Sep 2009.)
Osaka Osaka Prefecture (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
€5.0m | Series A | ||
€9.2m | Series B | ||
$26.0m | Series C | ||
$15.0m | Series D | ||
N/A | Acquisition | ||
Total Funding | €55.3m |
Related Content
Recent News about Santen
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Santen
EditACQUISITION by Allergan Sep 2016
ACQUISITION by Santen Jul 2016
exited
ACQUISITION by Alcon May 2024
ACQUISITION by Santen Sep 2020